Aftab Awan

528 total citations
20 papers, 393 citations indexed

About

Aftab Awan is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Aftab Awan has authored 20 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Aftab Awan's work include Herpesvirus Infections and Treatments (13 papers), T-cell and Retrovirus Studies (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Aftab Awan is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), T-cell and Retrovirus Studies (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Aftab Awan collaborates with scholars based in United Kingdom, U.S. Virgin Islands and South Sudan. Aftab Awan's co-authors include Hugh J. Field, H. J. Field, John S. Gibson, Josh Slater, Ricardo de la Fuente, R. de la Fuente, Mohit K. Baxi, Johan Harmenberg, Catherine M. Walker and Daria N. Love and has published in prestigious journals such as The FASEB Journal, Antimicrobial Agents and Chemotherapy and Journal of General Virology.

In The Last Decade

Aftab Awan

16 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aftab Awan United Kingdom 11 353 124 92 90 45 20 393
Barbara Garré Belgium 8 266 0.8× 65 0.5× 48 0.5× 61 0.7× 27 0.6× 11 322
P Thein Germany 9 212 0.6× 86 0.7× 43 0.5× 44 0.5× 20 0.4× 38 284
Antonie Neubauer Germany 15 398 1.1× 123 1.0× 66 0.7× 40 0.4× 69 1.5× 18 478
C. D. Sofaly United States 7 253 0.7× 90 0.7× 65 0.7× 86 1.0× 13 0.3× 7 355
Christine Brandmüller Germany 14 419 1.2× 188 1.5× 72 0.8× 41 0.5× 92 2.0× 17 546
Frank Fehler Germany 7 297 0.8× 76 0.6× 21 0.2× 35 0.4× 57 1.3× 8 324
A. Stokes United Kingdom 12 280 0.8× 84 0.7× 47 0.5× 29 0.3× 28 0.6× 12 319
A. Brack Germany 7 423 1.2× 117 0.9× 24 0.3× 17 0.2× 76 1.7× 8 473
Christopher D. Meiering United States 8 254 0.7× 93 0.8× 53 0.6× 13 0.1× 118 2.6× 8 439
Sharmila Manoj United States 6 196 0.6× 144 1.2× 26 0.3× 18 0.2× 66 1.5× 9 332

Countries citing papers authored by Aftab Awan

Since Specialization
Citations

This map shows the geographic impact of Aftab Awan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aftab Awan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aftab Awan more than expected).

Fields of papers citing papers by Aftab Awan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aftab Awan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aftab Awan. The network helps show where Aftab Awan may publish in the future.

Co-authorship network of co-authors of Aftab Awan

This figure shows the co-authorship network connecting the top 25 collaborators of Aftab Awan. A scholar is included among the top collaborators of Aftab Awan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aftab Awan. Aftab Awan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tulp, Orien L., et al.. (2022). Differential expression T4‐5’‐deiodinase activity in corpulent rats following cold exposure. The FASEB Journal. 36(S1). 1 indexed citations
2.
Tulp, Orien L. & Aftab Awan. (2022). Effect of a chromium-fructan complex on glycemic parameters in obese and obese-T2DM/NIDDM rats. Gastroenterology & Hepatology Open Access. 13(1). 5–10. 1 indexed citations
3.
4.
Tulp, Orien L., et al.. (2021). Haiti's Cholera Epidemic: When the Unexpected Must be Expected. The FASEB Journal. 35(S1). 1 indexed citations
5.
Tulp, Orien L., et al.. (2021). Enhanced Caloric Efficiency Contributes to Adiposity in LA/N//‐ cp Corpulent Rats. The FASEB Journal. 35(S1). 2 indexed citations
6.
Awan, Aftab, et al.. (2020). Characterization of Viraemic Cells in a Murine Model of EHV‐1 Infection. The FASEB Journal. 34(S1). 1–1. 1 indexed citations
8.
Harmenberg, Johan, Aftab Awan, Stefan Alenius, et al.. (2003). ME-609: A Treatment for Recurrent Herpes Simplex Virus Infections. Antiviral chemistry & chemotherapy. 14(4). 205–215. 14 indexed citations
9.
Awan, Aftab, et al.. (1998). Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease. Antiviral Research. 38(1). 43–53. 10 indexed citations
10.
Walker, Catherine M., Tim J. Fitzmaurice, Aftab Awan, et al.. (1998). Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion. Veterinary Microbiology. 62(4). 303–311. 18 indexed citations
11.
Awan, Aftab, Mohit K. Baxi, & Hugh J. Field. (1995). EHV 1-induced abortion in mice and its relationship to stage of gestation. Research in Veterinary Science. 59(2). 139–145. 20 indexed citations
12.
Awan, Aftab & Hugh J. Field. (1993). Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1. Antimicrobial Agents and Chemotherapy. 37(11). 2478–2482. 9 indexed citations
13.
Gibson, John S., Josh Slater, Aftab Awan, & Hugh J. Field. (1992). Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Archives of Virology. 123(3-4). 351–366. 78 indexed citations
14.
Field, Hugh J., Aftab Awan, & R. de la Fuente. (1992). Reinfection and reactivation of equine herpesvirus-1 in the mouse. Archives of Virology. 123(3-4). 409–419. 23 indexed citations
15.
Fuente, Ricardo de la, Aftab Awan, & Hugh J. Field. (1992). The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model. Antiviral Research. 18(1). 77–89. 29 indexed citations
16.
Awan, Aftab, John S. Gibson, & Hugh J. Field. (1991). A murine model for studying EHV-1-induced abortion. Research in Veterinary Science. 51(1). 94–99. 43 indexed citations
17.
Field, Hugh J., Aftab Awan, & Ricardo de la Fuente. (1991). Isolation of equine herpesvirus-1 mutants in the presence of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine: demonstration of resistance in vitro and in vivo. Antiviral Research. 16(1). 29–39. 7 indexed citations
18.
Duffus, W. P. H., Hugh J. Field, David A. Gray, et al.. (1991). The raising of equine colostrum‐deprived foals; maintenance and assessment of specific pathogen (EHV‐1/4) free status. Equine Veterinary Journal. 23(2). 111–115. 13 indexed citations
19.
Awan, Aftab, et al.. (1990). The Pathogenesis of Equine Herpesvirus Type 1 in the Mouse: A New Model for Studying Host Responses to the Infection. Journal of General Virology. 71(5). 1131–1140. 102 indexed citations
20.
Field, Hugh J. & Aftab Awan. (1990). Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease. Antimicrobial Agents and Chemotherapy. 34(5). 709–717. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026